Henry Schein, Inc.
HSIC
Peringkat dalam Saham
#2164
Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive... Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.
Harga Saham
$84.67
Terakhir disinkronkan: 2026-10-20
Kapitalisasi Pasar
$9.44B
Perubahan (1 hari)
0.84%
Perubahan (1 tahun)
31.83%
Negara
US
Perdagangan Henry Schein, Inc. (HSIC)
Kategori
Healthcare
Rasio P/E untuk Henry Schein, Inc. (HSIC)
Rasio P/E per October 2026 TTM: 24.73
Menurut laporan keuangan dan harga saham terbaru dari Henry Schein, Inc., rasio P/E saat ini (TTM) adalah 24.73. Pada akhir 2023, perusahaan memiliki rasio P/E sebesar 23.77.
Riwayat rasio P/E untuk Henry Schein, Inc. dari 2000 hingga 2026
Rasio P/E di akhir setiap tahun
| Tahun | Rasio P/E | Mengubah |
|---|---|---|
| 2026 (TTM) | 24.73 | 8.03% |
| 2024 | 22.89 | -3.70% |
| 2023 | 23.77 | 17.68% |
| 2022 | 20.20 | 21.43% |
| 2021 | 16.64 | -28.39% |
| 2020 | 23.23 | 69.76% |
| 2019 | 13.69 | -21.39% |
| 2018 | 17.41 | -19.52% |
| 2017 | 21.63 | 14.87% |
| 2016 | 18.83 | -11.62% |
| 2015 | 21.31 | 9.37% |
| 2014 | 19.48 | 9.02% |
| 2013 | 17.87 | 26.38% |
| 2012 | 14.14 | 14.16% |
| 2011 | 12.39 | -8.13% |
| 2010 | 13.48 | 13.54% |
| 2009 | 11.88 | 16.81% |
| 2008 | 10.17 | -49.24% |
| 2007 | 20.03 | -2.92% |
| 2006 | 20.63 | 4.84% |
| 2005 | 19.68 | 8.99% |
| 2004 | 18.06 | 7.06% |
| 2003 | 16.86 | 29.44% |
| 2002 | 13.03 | -54.17% |
| 2001 | 28.43 | -28.91% |
| 2000 | 39.99 | 0.00% |
Rasio P/E untuk perusahaan serupa atau pesaing
| Perusahaan | Rasio P/E | Perbedaan Rasio P/E | Negara |
|---|---|---|---|
| 26.02 | 5.23% |
US
|
|
| - | - |
US
|
|
| 34.08 | 37.81% |
US
|
|
| - | - |
US
|
|
| 45.62 | 84.47% |
AU
|
Bagaimana cara membaca P/E ratio?
Rasio Harga/Laba (P/E) mengukur hubungan antara harga saham perusahaan dan laba per sahamnya.
P/E yang rendah namun positif menunjukkan perusahaan dengan laba tinggi dibandingkan valuasinya saat ini dan mungkin dianggap undervalued. P/E negatif tinggi (mendekati 0) menunjukkan perusahaan yang mengalami kerugian besar.
Perusahaan dengan P/E di atas 30 atau negatif umumnya dianggap sebagai "saham pertumbuhan", artinya investor mengharapkan pertumbuhan atau keuntungan di masa depan.
Perusahaan dengan P/E positif di bawah 10 dianggap sebagai "saham bernilai", artinya perusahaan sudah sangat menguntungkan dan pertumbuhannya kemungkinan tidak besar.